Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer

PURPOSE: Erlotinib-gemcitabine combined chemotherapy is considered as the standard treatment for unresectable pancreatic cancer. This study aimed to determine the clinical factors associated with response to this treatment. MATERIALS AND METHODS: This retrospective study included 180 patients with u...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Yonsei Med J
Glavni autori: Moon, Do Chang, Lee, Hee Seung, Lee, Yong Il, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, Chung, Jae Bock, Bang, Seungmin
Format: Artigo
Jezik:Inglês
Izdano: Yonsei University College of Medicine 2016
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4960377/
https://ncbi.nlm.nih.gov/pubmed/27401642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2016.57.5.1124
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items